Medical Device Company

Company Overview

12 Month Historic Financials
Revenue: $11.9M
EBITDA: $4.4M
4 year AAGR: 182%
 
Other
Growth Potential: high
Operational Efficiency: excellent
Transition Challenges: above average
Balance Sheet Strength: above average
Industry Expertise: high

Bid History

Bid# Bidder Description Offer Price and Terms Total EV* NPV**
1. U.S. Private Equity Group $15.5M cash
$2.5M – 3 year note
$18.0M $18.0M
2. $200M U.S. Public Co. $15M
$5M – 5 year note
$4M – 2 year earn-out
$24.0M $23.6M
3. U.S. Private Equity Group $25M cash
$5M – 3 year note
$30.0M $30.0M
4. $10B U.K. Private Co. $19M cash $19.0M $19.0M
5. $2B U.S. Private Co. $25M cash
$7.95M – 3 year note
$32.95M $32.95M
6. $600M U.S. Private Co. $23M cash
$6M – 3 year note
$29.0M $29.0M

Accepted Offer:

7. US Private Equity Group $27.9M cash $27.9M $27.9M
* Enterprise Value ** Net Present Value
LockeBridge, LLC is an affiliate of LockeBridge Partners, Inc. - Member FINRA/SIPC
Join Our Email List Privacy Policy

Contact Information

LockeBridge, LLC
12 Waltham Street
Lexington, Massachusetts 02421
Tel: 781.676.2001
Fax: 877.907.1402

Contact us online for more information about our unique investment banking services model for business owners, and advisors.

Copyright © 2006-2017 LockeBridge, LLC. All rights reserved.